Arrowhead Pharmaceuticals (ARWR) Non-cash Items (2016 - 2022)
Arrowhead Pharmaceuticals' Non-cash Items history spans 11 years, with the latest figure at $2.3 million for Q1 2022.
- For Q1 2022, Non-cash Items fell 98.66% year-over-year to $2.3 million; the TTM value through Mar 2022 reached $2.3 million, down 98.66%, while the annual FY2021 figure was $149.5 million, 5011.59% up from the prior year.
- Non-cash Items reached $2.3 million in Q1 2022 per ARWR's latest filing, down from $149.3 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $224.7 million in Q2 2021 to a low of $2.3 million in Q1 2022.
- Average Non-cash Items over 5 years is $56.2 million, with a median of $4.2 million recorded in 2018.
- Peak YoY movement for Non-cash Items: surged 11048.52% in 2018, then plummeted 98.66% in 2022.
- A 5-year view of Non-cash Items shows it stood at $35.7 million in 2018, then crashed by 91.06% to $3.2 million in 2019, then decreased by 19.77% to $2.6 million in 2020, then surged by 5741.52% to $149.3 million in 2021, then tumbled by 98.43% to $2.3 million in 2022.
- Per Business Quant, the three most recent readings for ARWR's Non-cash Items are $2.3 million (Q1 2022), $149.3 million (Q4 2021), and $149.5 million (Q3 2021).